IL18 and lung cancer: Hui Kong et al. [11] showed that the level of NLRP3 inflammasome, IL-1β, and IL-18 in lung cancer cells and tissues was significantly increased compared to that in normal lung cells and para-carcinoma tissues, which indicated that NLRP3 inflammasome mediated inflammatory response was involved in the progress of lung cancer.